IRCT20151228025732N70 IRCT 2021-12-07 Semnan University of Medical Sciences Evaluation of the protective effect of Curcuma Longa induced nephrotoxicity in patients with cancer Evaluation of the protective effect of Curcuma Longa against cisplatin induced nephrotoxicity in patients with cancer 2021-12-06 anticipated 30 Complete https://irct.ir/trial/60299 interventional Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: Numbers 1 to 30 are written on paper and all of them are placed in sealed envelopes. Patients are then asked to select an envelope each. Patients whose number in the envelope is odd will be in the intervention group and patients whose number in the envelope is even will be in the control group, Blinding description: Drug packaging is coded. So that the patients are unaware of the drug content packaging and intervention that they receive. N/A Cisplatin induced nephrotoxicity. Intervention 1: Intervention group: In addition to routine treatments, this group consumes one turmeric tablet of "Dineh Iran" company (Each tablet contains 450 mg of turmeric rhizome powder and 50 mg of turmeric extract, which is standardized based on 5.47 mg of curcumin) with lunch 3 days before the start of cisplatin treatment. Intervention 2: Control group: This group only receives routine treatments. Undecided - It is not yet known if there will be a plan to make this available Justification or reason for indecision in sharing IPD is There is no more information.